2 completed, 1 terminated, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Dr. John Muscedere: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceragenin Coated Endotracheal Tubes for the Prevention of Ventilator Associated Pneumonia CeraShield Endotracheal Tube, Endotracheal tube with subglottic secretion drainage - Ventilator Associated Pneumonia | Not applicable | Unknown | Dr. John Muscedere | 400 | 2023-02-21 | 2024-04-05 |
| Furosemide as Supportive Therapy for COVID-19 Respiratory Failure Nebulized Furosemide, Nebulized Saline - Covid19, Respiratory Failure | Phase 2 / Phase 3 | Terminated | Dr. John Muscedere | 40 | 2021-04-16 | 2023-12-11 |
| Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Study Multi-Center Study No interventions - Frailty, Critical Illness | Completed | Dr. John Muscedere | 700 | 2019-09-01 | 2023-12-11 | |
| Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients Critical Illness | Completed | Dr. John Muscedere | 50 | 2017-08-01 | 2020-10-27 |
Critical Illness (2) · Frailty (2) · COVID-19 (1) · Pneumonia, Ventilator-Associated (1) · Respiratory Insufficiency (1)
Canada (4)